您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报 (医学版) ›› 2019, Vol. 57 ›› Issue (1): 68-74.doi: 10.6040/j.issn.1671-7554.0.2018.633

• • 上一篇    下一篇

双源CT Flash低剂量扫描对儿童表浅血管性疾病诊治的临床价值

于鑫鑫1,2,郭磊3,程召平2,段艳华2,王锡明2   

  1. 1. 山东大学齐鲁医学院, 山东 济南 250012;2. 山东省医学影像学研究所影像科, 山东 济南 250021;3. 山东大学齐鲁儿童医院介入影像科, 山东 济南 250021
  • 发布日期:2022-09-27
  • 通讯作者: 王锡明. E-mail:wxming369@163.com
  • 基金资助:
    国家自然科学基金(81371548、81571672);山东省泰山学者专项经费(2015年)

Clinical value of flash spiral dual-source CT with low-dose scan for children with superficial vascular anomalies

YU Xinxin1,2, GUO Lei3, CHENG Zhaoping2, DUAN Yanhua2, WANG Ximing2   

  1. 1. Shandong University Cheeloo College of Medicine, Jinan 250012, Shandong, China;
    2. Department of Radiology, Shandong Medical Imaging Research Institute, Jinan 250021, Shandong, China;
    3. Department of Interventional Radiology, Qilu Childrens Hospital of Shandong University, Jinan 250021, Shandong, China
  • Published:2022-09-27

PDF (PC)

40

摘要： 目的 探讨双源CT Flash低剂量扫描对儿童表浅血管性疾病诊治的临床价值。 方法 对临床疑诊或超声提示为高流量血管性疾病的患者行双源CT Flash大螺距联合个体化低剂量扫描,同时记录单期相扫描时间、单期相剂量长度乘积及全程剂量长度乘积,计算平均有效辐射剂量。所得图像进行三维CT重建,由两位中级以上医师对图像给予诊断,根据诊断结果制定临床治疗方案并随访治疗效果。 结果 35例患者中共发现46处病变(平均7.4岁),其中血管瘤9例(9/35,25.71%),动静脉畸形14例(14/35,40.00%),静脉畸形12例(12/35,34.29%),单期相及全程平均有效辐射剂量分别为(0.45±0.16)、(1.31±0.42)mSV,单期相平均扫描时间为(0.69±0.15)s。 结论 双源CT Flash大螺距联合个体化低剂量扫描及三维重建技术可清晰地显示血管性病变同时明显降低辐射剂量,为临床诊治提供依据。

关键词: 双源CT, 低剂量, 血管瘤, 血管畸形, 治疗

Abstract: Objective To evaluate the diagnostic and therapeutic value of flash spiral dual-source CT with low-dose scan for children with superficial vascular anomalies(VAs). Methods For patients with suspected VAs and affluent blood flow pre-detected by ultrasound, CT was performed with high-pitch mode, individualized low-dose scan protocol and three-dimensional reformation. Single-phase scan time, single-phase dose-length product and total dose-length product were recorded, and the effective radiation doses were calculated. Images were diagnosed by two physicians, therapeutic plans were formulated, and the therapeutic efficacy was followed up. Results Altogether 46 lesions were identified in 35 children(mean age of 7.4 years), including 9 with hemangioma(9/35, 25.71%), 14 with arteriovenous malformation(14/35, 40.00%), and 12 with venous malformation(12/35, 34.29%). The average effective radiation doses of a single phase and total procedure were(0.45±0.16)mSV and(1.31±0.42)mSV, respectively. The average scan time of a single phase was(0.69±0.15)s. Conclusion Flash spiral dual-source CT with high-pitch mode, low-dose scan protocol and 3D reformation is an effective modality for imaging VAs with affluent blood flow in children. It can clearly show lesions and significantly reduce the radiation doses at the same time.

Key words: Dual-source CT, Low dose, Hemangioma, Vascular malformation, Treatment

中图分类号: 

  • R445.3
[1] 杨秀娟, 郑家伟. 血管瘤与脉管畸形的鉴别诊断研究进展[J]. 上海口腔医学, 2007, 16(5): 542-546. YANG Xiujuan, ZHENG Jiawei. Diagnosis of hemangiomas and vascular malformations[J]. Shanghai Journal of Stomatology, 2007, 16(5): 542-546.
[2] Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics[J]. Plast Reconstr Surg, 1982, 69(3): 412-422.
[3] Jackson IT CR, Potparic Z. Hemangiomas, vascular malformations, and lymphovenous malformations: classification and methods of treatment[J]. Plast Reconstr Surg, 1993, 91(7): 1216-1230.
[4] 中华口腔医学会口腔颌面外科专业委员会脉管性疾病学组. 口腔颌面部血管瘤治疗指南[J]. 中华口腔颌面外科杂志, 2011, 9(1): 61-67. Department of Stomatology and maxillofacial surgery, Chinese Stomatological Association Specialized Committee. The protocol of treatment guideline of oral and maxillofacial hemangiomas[J]. China Journal of Oral and Maxillofacial Surgery, 2011, 9(1): 61-67.
[5] Mulligan PR, Prajapati HJ, Martin LG, et al. Vascular anomalies: classification, imaging characteristics and implications for interventional radiology treatment approaches[J]. Br J Radiol, 2014, 87(1035): 20130392. doi: 10.1259/bjr.20130392.
[6] Behr GG, Johnson C. Vascular anomalies: hemangiomas and beyond-part 1, Fast-flow lesions[J]. AJR Am J Roentgenol, 2013, 200(2): 414-422.
[7] Jarrett DY, Ali M, Chaudry G. Imaging of vascular anomalies[J]. Dermatol Clin, 2013, 31(2): 251-266.
[8] Restrepo R. Multimodality imaging of vascular anomalies[J]. Pediatr Radiol, 2013, 43(Suppl 1): S141-154. doi: 10.1007/s00247-012-2584-y.
[9] Thawait SK, Puttgen K, Carrino JA, et al. MR imaging characteristics of soft tissue vascular anomalies in children[J]. Eur J Pediatr, 2013, 172(5): 591-600.
[10] 施美华, 钟玉敏, 殷敏智, 等. 儿童软组织脉管性病变的影像诊断[J]. 放射学实践, 2013, 28(7): 724-729. SHI Meihua, ZHONG Yumin, YIN Minzhi, et al. Imaging diagnosis of soft-tissue vascular anomalies in children[J]. Radiol Practice, 2013, 28(7): 724-729.
[11] Chaudry MI, Manzoor MU, Turner RD, et al. Diagnostic imaging of vascular anomalies[J]. Facial Plast Surg, 2012, 28(6): 563-574.
[12] Dubois J PH, Garel L, Powell J, et al. Soft-tissue hemangiomas in infants and children: diagnosis using Doppler sonography[J]. AJR Am J Roentgenol,1998, 171(1): 247-252.
[13] Dubois J, Alison M. Vascular anomalies: what a radiologist needs to know[J]. Pediatr Radiol, 2010, 40(6): 895-905.
[14] Anzidei M, Cavallo Marincola B, Napoli A, et al. Low-dose contrast-enhanced time-resolved MR angiography at 3T: diagnostic accuracy for treatment planning and follow-up of vascular malformations[J]. Clin Radiol, 2011, 66(12): 1181-1192.
[15] Lidsky ME, Spritzer CE, Shortell CK. The role of dynamic contrast-enhanced magnetic resonance imaging in the diagnosis and management of patients with vascular malformations[J]. J Vasc Surg, 2012, 56(3): 757-764.
[16] Warren TA, Gandhi M, Panizza B. Pictorial review: Vascular anomalies of the head and neck[J]. J Med Imaging Radiat Oncol, 2012, 56(1): 84-92.
[17] Ait-Ali L, Andreassi MG, Foffa I, et al. Cumulative patient effective dose and acute radiation-induced chromosomal DNA damage in children with congenital heart disease[J]. Heart, 2010, 96(4): 269-274.
[18] Yu L BM, Thomas KB, Fletcher JG, et al. Optimal tube potential for radiation dose reduction in pediatric CT: principles, clinical implementations, and pitfalls[J]. Radiographics, 2011, 31(3): 835-848.
[19] Yang B, Li L, Zhang LX, et al. Clinical characteristics and treatment options of infantile vascular anomalies[J]. Medicine, 2015, 94(40): e1717. doi: 10.1097/MD.0000000000001717.
[20] Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy[J]. N Engl J Med, 2008, 358(24): 2649-2651.
[21] Vaidya S, Cooke D, Kogut M, et al. Imaging and percutaneous treatment of vascular anomalies[J]. Semin Intervent Radiol, 2008, 25(3): 216-233.
[22] Sadick M, Wohlgemuth WA, Huelse R, et al. Interdisciplinary management of head and neck vascular anomalies: clinical presentation, diagnostic findings and minimalinvasive therapies[J]. Eur J Radiol Open, 2017, 4: 63-68. doi: 10.1016/j.ejro.2017.05.001.
[23] Kolokythas A. Vascular malformations and their treatment in the growing patient[J]. Oral Maxillofac Surg Clin North Am, 2016, 28(1): 91-104.
[24] Lee BB BI, Baumgartner I, Berlien HP, et al. Consensus document of the International Union of Angiology(IUA)-2013. Current concept on the management of arterio-venous malformations[J]. Int Angiol, 2013, 32(1): 9-36.
[25] Mikami T, Hirano T, Sugino T, et al. Presurgical planning for arteriovenous malformations using multidetector row CT[J]. Neurosurg Rev, 2012, 35(3): 393-400.
[26] Muller-Wille R, Wildgruber M, Sadick M, et al. Vascular anomalies(Part II): interventional therapy of peripheral vascular malformations[J]. Rofo, 2018. doi: 10.1055/s-0044-101266.
[27] Gemmete JJ, Pandey AS, Kasten SJ, et al. Endovascular methods for the treatment of vascular anomalies[J]. Neuroimaging Clin N Am, 2013, 23(4): 703-728.
[1] 巩性军，吴树明，张供，李守先，庞昕焱. 无顶冠状静脉窦综合征的诊断和外科治疗[J]. 山东大学学报(医学版), 2209, 47(6): 129-.
[2] 孙红林,管玉强,于培儒,李磊,杜庆霞,丁浩. 支架植入治疗儿童主动脉缩窄并高血压的可行性及近中期疗效[J]. 山东大学学报 (医学版), 2026, 64(4): 58-62.
[3] 林明霞,刘桂斌,马燕花,连曌昱,任洋洋. ATP酶铜转运蛋白α介导的铜死亡途径及在肿瘤治疗中的价值[J]. 山东大学学报 (医学版), 2026, 64(4): 117-124.
[4] 樊呈敏,宋静雨,于书彦,毛雪琴. 舒肝解郁胶囊治疗青少年抑郁障碍的研究进展[J]. 山东大学学报 (医学版), 2026, 64(3): 17-23.
[5] 李雪凯,孙淋涵,刘端瑞,倪阳. 乳酸化修饰在肿瘤炎癌进程中的功能与机制研究进展[J]. 山东大学学报 (医学版), 2025, 63(9): 65-76.
[6] 国科,陈绪军,郑宝石,施超,黄克力,曹勇,陈军,吴东凯,张晓慎,罗俊辉,申林,莫绪明,杨岷,王晓武,雷印胜,田茂州,王振东,孟自力,孙忠东,李有金,陆辉辉,孟春营,高峰,陈黔苏,郭能瑞,柳德斌,张楠,林宇,陈文生,宋保国,方智,王海晨,廖晓波,徐朝军. 快通道拔管在全动脉冠脉旁路移植术的多中心临床效果[J]. 山东大学学报 (医学版), 2025, 63(5): 26-32.
[7] 赵芸慕兰,高海燕. 中、高危分化型甲状腺癌患者术后 131I治疗反应及预后的影响因素[J]. 山东大学学报 (医学版), 2025, 63(2): 21-28.
[8] 韩馨玮,牛月,魏代敏. 激素替代方案准备内膜的冻胚移植前雌激素治疗时间对新生儿体质量的影响[J]. 山东大学学报 (医学版), 2025, 63(11): 46-52.
[9] 黄艳,周应芳,彭超. 青少年子宫内膜异位症的管理要点和策略[J]. 山东大学学报 (医学版), 2025, 63(10): 8-12.
[10] 薛铭,梁静,凌斌. 各种类型子宫内膜异位症疼痛特点及治疗研究进展[J]. 山东大学学报 (医学版), 2025, 63(10): 13-19.
[11] 山东省医学会乳腺疾病多学科联合委员会. 乳腺癌多学科协作诊疗山东共识(2024年版)[J]. 山东大学学报 (医学版), 2025, 63(1): 10-16.
[12] 宋雅雯,郭联涛,孔德光,孙圣荣. VTCN1导致HR+乳腺癌预后不良及内分泌治疗耐药[J]. 山东大学学报 (医学版), 2025, 63(1): 43-59.
[13] 刘晶晶,庞婧,赵晓丹,林昕,付敏,陈静静. 基于乳腺X线摄影及DCE-MRI机器学习模型预测乳腺癌新辅助治疗后病理完全缓解:双中心研究[J]. 山东大学学报 (医学版), 2025, 63(1): 60-72.
[14] 陈忠,王盛. 主动脉疾病治疗现状及思考[J]. 山东大学学报 (医学版), 2024, 62(9): 1-6.
[15] 范立彬,张鸿坤. 腹主动脉瘤腔内修复术后Ⅱ型内漏的预防及治疗进展[J]. 山东大学学报 (医学版), 2024, 62(9): 55-60.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发